nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP3A4—bone cancer	0.352	0.505	CbGaD
Etoricoxib—PTGS2—bone cancer	0.345	0.495	CbGaD
Etoricoxib—PTGS2—Cisplatin—bone cancer	0.0363	0.595	CbGbCtD
Etoricoxib—CYP2C9—Cisplatin—bone cancer	0.0123	0.202	CbGbCtD
Etoricoxib—CYP2D6—Doxorubicin—bone cancer	0.00756	0.124	CbGbCtD
Etoricoxib—CYP3A4—Doxorubicin—bone cancer	0.00481	0.0788	CbGbCtD
Etoricoxib—Vemurafenib—BRAF—bone cancer	0.00422	0.392	CrCbGaD
Etoricoxib—Vismodegib—SMO—bone cancer	0.00404	0.376	CrCbGaD
Etoricoxib—Vemurafenib—CYP3A4—bone cancer	0.000937	0.0871	CrCbGaD
Etoricoxib—Celecoxib—CYP3A4—bone cancer	0.000551	0.0512	CrCbGaD
Etoricoxib—Celecoxib—PTGS2—bone cancer	0.000539	0.0501	CrCbGaD
Etoricoxib—Vismodegib—CYP3A4—bone cancer	0.000472	0.0438	CrCbGaD
Etoricoxib—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00022	0.00171	CcSEcCtD
Etoricoxib—Renal failure—Methotrexate—bone cancer	0.000218	0.0017	CcSEcCtD
Etoricoxib—Abdominal distension—Doxorubicin—bone cancer	0.000217	0.00169	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Epirubicin—bone cancer	0.000216	0.00169	CcSEcCtD
Etoricoxib—Stomatitis—Methotrexate—bone cancer	0.000216	0.00169	CcSEcCtD
Etoricoxib—Conjunctivitis—Methotrexate—bone cancer	0.000215	0.00168	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Epirubicin—bone cancer	0.000212	0.00166	CcSEcCtD
Etoricoxib—Feeling abnormal—Cisplatin—bone cancer	0.000212	0.00166	CcSEcCtD
Etoricoxib—Weight increased—Epirubicin—bone cancer	0.000212	0.00165	CcSEcCtD
Etoricoxib—Haematuria—Methotrexate—bone cancer	0.000211	0.00165	CcSEcCtD
Etoricoxib—Pancreatitis—Doxorubicin—bone cancer	0.000211	0.00165	CcSEcCtD
Etoricoxib—Hyperglycaemia—Epirubicin—bone cancer	0.00021	0.00164	CcSEcCtD
Etoricoxib—Angina pectoris—Doxorubicin—bone cancer	0.00021	0.00164	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Methotrexate—bone cancer	0.00021	0.00164	CcSEcCtD
Etoricoxib—Epistaxis—Methotrexate—bone cancer	0.000209	0.00163	CcSEcCtD
Etoricoxib—Pneumonia—Epirubicin—bone cancer	0.000209	0.00163	CcSEcCtD
Etoricoxib—Infestation NOS—Epirubicin—bone cancer	0.000207	0.00162	CcSEcCtD
Etoricoxib—Infestation—Epirubicin—bone cancer	0.000207	0.00162	CcSEcCtD
Etoricoxib—Bronchitis—Doxorubicin—bone cancer	0.000207	0.00161	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000206	0.0016	CcSEcCtD
Etoricoxib—Renal failure—Epirubicin—bone cancer	0.000204	0.00159	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Epirubicin—bone cancer	0.000203	0.00159	CcSEcCtD
Etoricoxib—Jaundice—Epirubicin—bone cancer	0.000202	0.00158	CcSEcCtD
Etoricoxib—Stomatitis—Epirubicin—bone cancer	0.000202	0.00158	CcSEcCtD
Etoricoxib—Urinary tract infection—Epirubicin—bone cancer	0.000202	0.00157	CcSEcCtD
Etoricoxib—Conjunctivitis—Epirubicin—bone cancer	0.000202	0.00157	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Doxorubicin—bone cancer	0.0002	0.00156	CcSEcCtD
Etoricoxib—Haemoglobin—Methotrexate—bone cancer	0.0002	0.00156	CcSEcCtD
Etoricoxib—Haemorrhage—Methotrexate—bone cancer	0.000199	0.00155	CcSEcCtD
Etoricoxib—Hepatitis—Methotrexate—bone cancer	0.000199	0.00155	CcSEcCtD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—ATF1—bone cancer	0.000198	0.00192	CbGpPWpGaD
Etoricoxib—Haematuria—Epirubicin—bone cancer	0.000198	0.00154	CcSEcCtD
Etoricoxib—Pharyngitis—Methotrexate—bone cancer	0.000198	0.00154	CcSEcCtD
Etoricoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TP53—bone cancer	0.000197	0.00191	CbGpPWpGaD
Etoricoxib—Urinary tract disorder—Methotrexate—bone cancer	0.000197	0.00153	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Doxorubicin—bone cancer	0.000197	0.00153	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Epirubicin—bone cancer	0.000196	0.00153	CcSEcCtD
Etoricoxib—Weight increased—Doxorubicin—bone cancer	0.000196	0.00153	CcSEcCtD
Etoricoxib—Epistaxis—Epirubicin—bone cancer	0.000196	0.00153	CcSEcCtD
Etoricoxib—Urethral disorder—Methotrexate—bone cancer	0.000195	0.00152	CcSEcCtD
Etoricoxib—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000195	0.00189	CbGpPWpGaD
Etoricoxib—Sinusitis—Epirubicin—bone cancer	0.000195	0.00152	CcSEcCtD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TGFBR2—bone cancer	0.000194	0.00188	CbGpPWpGaD
Etoricoxib—Hyperglycaemia—Doxorubicin—bone cancer	0.000194	0.00151	CcSEcCtD
Etoricoxib—MAPK14—B Cell Receptor Signaling Pathway—BRAF—bone cancer	0.000194	0.00187	CbGpPWpGaD
Etoricoxib—Pneumonia—Doxorubicin—bone cancer	0.000193	0.00151	CcSEcCtD
Etoricoxib—Infestation NOS—Doxorubicin—bone cancer	0.000192	0.0015	CcSEcCtD
Etoricoxib—Infestation—Doxorubicin—bone cancer	0.000192	0.0015	CcSEcCtD
Etoricoxib—MAPK14—Regulation of retinoblastoma protein—JUN—bone cancer	0.000192	0.00186	CbGpPWpGaD
Etoricoxib—MAPK14—AGE/RAGE pathway—JUN—bone cancer	0.000192	0.00186	CbGpPWpGaD
Etoricoxib—MAPK14—TSH signaling pathway—JUN—bone cancer	0.000192	0.00186	CbGpPWpGaD
Etoricoxib—Visual impairment—Methotrexate—bone cancer	0.000192	0.0015	CcSEcCtD
Etoricoxib—MAPK14—p73 transcription factor network—MDM2—bone cancer	0.000191	0.00185	CbGpPWpGaD
Etoricoxib—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00019	0.00148	CcSEcCtD
Etoricoxib—MAPK14—Insulin Signaling—IGF1R—bone cancer	0.00019	0.00184	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Cisplatin—bone cancer	0.00019	0.00148	CcSEcCtD
Etoricoxib—MAPK14—BCR signaling pathway—JUN—bone cancer	0.00019	0.00183	CbGpPWpGaD
Etoricoxib—Renal failure—Doxorubicin—bone cancer	0.000189	0.00147	CcSEcCtD
Etoricoxib—Erythema multiforme—Methotrexate—bone cancer	0.000188	0.00147	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Doxorubicin—bone cancer	0.000188	0.00147	CcSEcCtD
Etoricoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000187	0.00181	CbGpPWpGaD
Etoricoxib—Haemoglobin—Epirubicin—bone cancer	0.000187	0.00146	CcSEcCtD
Etoricoxib—Stomatitis—Doxorubicin—bone cancer	0.000187	0.00146	CcSEcCtD
Etoricoxib—Jaundice—Doxorubicin—bone cancer	0.000187	0.00146	CcSEcCtD
Etoricoxib—MAPK14—AGE/RAGE pathway—MMP9—bone cancer	0.000187	0.00181	CbGpPWpGaD
Etoricoxib—Conjunctivitis—Doxorubicin—bone cancer	0.000187	0.00146	CcSEcCtD
Etoricoxib—Urinary tract infection—Doxorubicin—bone cancer	0.000187	0.00146	CcSEcCtD
Etoricoxib—Hepatitis—Epirubicin—bone cancer	0.000186	0.00145	CcSEcCtD
Etoricoxib—Haemorrhage—Epirubicin—bone cancer	0.000186	0.00145	CcSEcCtD
Etoricoxib—Eye disorder—Methotrexate—bone cancer	0.000186	0.00145	CcSEcCtD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000186	0.0018	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—CDK4—bone cancer	0.000186	0.0018	CbGpPWpGaD
Etoricoxib—Tinnitus—Methotrexate—bone cancer	0.000186	0.00145	CcSEcCtD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—MDM2—bone cancer	0.000185	0.0018	CbGpPWpGaD
Etoricoxib—Hypoaesthesia—Epirubicin—bone cancer	0.000185	0.00145	CcSEcCtD
Etoricoxib—Asthenia—Cisplatin—bone cancer	0.000185	0.00144	CcSEcCtD
Etoricoxib—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000185	0.00179	CbGpPWpGaD
Etoricoxib—Pharyngitis—Epirubicin—bone cancer	0.000185	0.00144	CcSEcCtD
Etoricoxib—Cardiac disorder—Methotrexate—bone cancer	0.000185	0.00144	CcSEcCtD
Etoricoxib—Urinary tract disorder—Epirubicin—bone cancer	0.000184	0.00143	CcSEcCtD
Etoricoxib—Oedema peripheral—Epirubicin—bone cancer	0.000183	0.00143	CcSEcCtD
Etoricoxib—Haematuria—Doxorubicin—bone cancer	0.000183	0.00143	CcSEcCtD
Etoricoxib—Connective tissue disorder—Epirubicin—bone cancer	0.000183	0.00143	CcSEcCtD
Etoricoxib—MAPK14—CDC42 signaling events—JUN—bone cancer	0.000183	0.00177	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000183	0.00177	CbGpPWpGaD
Etoricoxib—Urethral disorder—Epirubicin—bone cancer	0.000183	0.00142	CcSEcCtD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—BRAF—bone cancer	0.000182	0.00176	CbGpPWpGaD
Etoricoxib—Hepatobiliary disease—Doxorubicin—bone cancer	0.000182	0.00142	CcSEcCtD
Etoricoxib—Epistaxis—Doxorubicin—bone cancer	0.000181	0.00141	CcSEcCtD
Etoricoxib—Angiopathy—Methotrexate—bone cancer	0.000181	0.00141	CcSEcCtD
Etoricoxib—Sinusitis—Doxorubicin—bone cancer	0.00018	0.0014	CcSEcCtD
Etoricoxib—Immune system disorder—Methotrexate—bone cancer	0.00018	0.0014	CcSEcCtD
Etoricoxib—Visual impairment—Epirubicin—bone cancer	0.000179	0.0014	CcSEcCtD
Etoricoxib—Mediastinal disorder—Methotrexate—bone cancer	0.000179	0.0014	CcSEcCtD
Etoricoxib—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000179	0.00174	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—RB1—bone cancer	0.000179	0.00173	CbGpPWpGaD
Etoricoxib—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000178	0.00172	CbGpPWpGaD
Etoricoxib—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000177	0.00171	CbGpPWpGaD
Etoricoxib—Diarrhoea—Cisplatin—bone cancer	0.000176	0.00137	CcSEcCtD
Etoricoxib—Erythema multiforme—Epirubicin—bone cancer	0.000176	0.00137	CcSEcCtD
Etoricoxib—Alopecia—Methotrexate—bone cancer	0.000176	0.00137	CcSEcCtD
Etoricoxib—Mental disorder—Methotrexate—bone cancer	0.000174	0.00136	CcSEcCtD
Etoricoxib—Eye disorder—Epirubicin—bone cancer	0.000174	0.00136	CcSEcCtD
Etoricoxib—MAPK14—Cellular responses to stress—EZH2—bone cancer	0.000174	0.00168	CbGpPWpGaD
Etoricoxib—Tinnitus—Epirubicin—bone cancer	0.000174	0.00135	CcSEcCtD
Etoricoxib—Erythema—Methotrexate—bone cancer	0.000173	0.00135	CcSEcCtD
Etoricoxib—Malnutrition—Methotrexate—bone cancer	0.000173	0.00135	CcSEcCtD
Etoricoxib—Haemoglobin—Doxorubicin—bone cancer	0.000173	0.00135	CcSEcCtD
Etoricoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—JUN—bone cancer	0.000173	0.00168	CbGpPWpGaD
Etoricoxib—Cardiac disorder—Epirubicin—bone cancer	0.000173	0.00135	CcSEcCtD
Etoricoxib—Flushing—Epirubicin—bone cancer	0.000173	0.00135	CcSEcCtD
Etoricoxib—Haemorrhage—Doxorubicin—bone cancer	0.000172	0.00134	CcSEcCtD
Etoricoxib—Hepatitis—Doxorubicin—bone cancer	0.000172	0.00134	CcSEcCtD
Etoricoxib—MAPK14—Thromboxane A2 receptor signaling—EGFR—bone cancer	0.000172	0.00166	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000172	0.00166	CbGpPWpGaD
Etoricoxib—Hypoaesthesia—Doxorubicin—bone cancer	0.000171	0.00134	CcSEcCtD
Etoricoxib—Pharyngitis—Doxorubicin—bone cancer	0.000171	0.00133	CcSEcCtD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—MET—bone cancer	0.000171	0.00165	CbGpPWpGaD
Etoricoxib—Urinary tract disorder—Doxorubicin—bone cancer	0.00017	0.00133	CcSEcCtD
Etoricoxib—Oedema peripheral—Doxorubicin—bone cancer	0.00017	0.00132	CcSEcCtD
Etoricoxib—Dysgeusia—Methotrexate—bone cancer	0.00017	0.00132	CcSEcCtD
Etoricoxib—Connective tissue disorder—Doxorubicin—bone cancer	0.000169	0.00132	CcSEcCtD
Etoricoxib—Angiopathy—Epirubicin—bone cancer	0.000169	0.00132	CcSEcCtD
Etoricoxib—Urethral disorder—Doxorubicin—bone cancer	0.000169	0.00132	CcSEcCtD
Etoricoxib—Immune system disorder—Epirubicin—bone cancer	0.000168	0.00131	CcSEcCtD
Etoricoxib—Mediastinal disorder—Epirubicin—bone cancer	0.000168	0.00131	CcSEcCtD
Etoricoxib—Arrhythmia—Epirubicin—bone cancer	0.000166	0.0013	CcSEcCtD
Etoricoxib—Visual impairment—Doxorubicin—bone cancer	0.000166	0.0013	CcSEcCtD
Etoricoxib—Alopecia—Epirubicin—bone cancer	0.000165	0.00128	CcSEcCtD
Etoricoxib—Vomiting—Cisplatin—bone cancer	0.000164	0.00128	CcSEcCtD
Etoricoxib—Vision blurred—Methotrexate—bone cancer	0.000163	0.00127	CcSEcCtD
Etoricoxib—Mental disorder—Epirubicin—bone cancer	0.000163	0.00127	CcSEcCtD
Etoricoxib—Erythema multiforme—Doxorubicin—bone cancer	0.000163	0.00127	CcSEcCtD
Etoricoxib—Rash—Cisplatin—bone cancer	0.000162	0.00127	CcSEcCtD
Etoricoxib—Dermatitis—Cisplatin—bone cancer	0.000162	0.00127	CcSEcCtD
Etoricoxib—Malnutrition—Epirubicin—bone cancer	0.000162	0.00126	CcSEcCtD
Etoricoxib—Erythema—Epirubicin—bone cancer	0.000162	0.00126	CcSEcCtD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—JUN—bone cancer	0.000161	0.00156	CbGpPWpGaD
Etoricoxib—Eye disorder—Doxorubicin—bone cancer	0.000161	0.00126	CcSEcCtD
Etoricoxib—Tinnitus—Doxorubicin—bone cancer	0.000161	0.00125	CcSEcCtD
Etoricoxib—Anaemia—Methotrexate—bone cancer	0.00016	0.00125	CcSEcCtD
Etoricoxib—Flushing—Doxorubicin—bone cancer	0.00016	0.00125	CcSEcCtD
Etoricoxib—Cardiac disorder—Doxorubicin—bone cancer	0.00016	0.00125	CcSEcCtD
Etoricoxib—Flatulence—Epirubicin—bone cancer	0.00016	0.00125	CcSEcCtD
Etoricoxib—Dysgeusia—Epirubicin—bone cancer	0.000159	0.00124	CcSEcCtD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000158	0.00153	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 cascade initiated on plasma membrane—JUN—bone cancer	0.000157	0.00152	CbGpPWpGaD
Etoricoxib—Angiopathy—Doxorubicin—bone cancer	0.000156	0.00122	CcSEcCtD
Etoricoxib—Muscle spasms—Epirubicin—bone cancer	0.000156	0.00122	CcSEcCtD
Etoricoxib—Immune system disorder—Doxorubicin—bone cancer	0.000156	0.00121	CcSEcCtD
Etoricoxib—Mediastinal disorder—Doxorubicin—bone cancer	0.000155	0.00121	CcSEcCtD
Etoricoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JUN—bone cancer	0.000155	0.0015	CbGpPWpGaD
Etoricoxib—Arrhythmia—Doxorubicin—bone cancer	0.000154	0.0012	CcSEcCtD
Etoricoxib—Nausea—Cisplatin—bone cancer	0.000153	0.00119	CcSEcCtD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—bone cancer	0.000153	0.00148	CbGpPWpGaD
Etoricoxib—Vision blurred—Epirubicin—bone cancer	0.000153	0.00119	CcSEcCtD
Etoricoxib—MAPK14—MyD88 dependent cascade initiated on endosome—JUN—bone cancer	0.000152	0.00147	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—ATF1—bone cancer	0.000152	0.00147	CbGpPWpGaD
Etoricoxib—Alopecia—Doxorubicin—bone cancer	0.000152	0.00119	CcSEcCtD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—MDM2—bone cancer	0.000152	0.00147	CbGpPWpGaD
Etoricoxib—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000152	0.00147	CbGpPWpGaD
Etoricoxib—Cough—Methotrexate—bone cancer	0.000151	0.00118	CcSEcCtD
Etoricoxib—Mental disorder—Doxorubicin—bone cancer	0.000151	0.00118	CcSEcCtD
Etoricoxib—MAPK14—AGE/RAGE pathway—EGFR—bone cancer	0.000151	0.00146	CbGpPWpGaD
Etoricoxib—Erythema—Doxorubicin—bone cancer	0.00015	0.00117	CcSEcCtD
Etoricoxib—Malnutrition—Doxorubicin—bone cancer	0.00015	0.00117	CcSEcCtD
Etoricoxib—Anaemia—Epirubicin—bone cancer	0.00015	0.00117	CcSEcCtD
Etoricoxib—MAPK14—TCR Signaling Pathway—JUN—bone cancer	0.00015	0.00145	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—EGFR—bone cancer	0.000149	0.00144	CbGpPWpGaD
Etoricoxib—Agitation—Epirubicin—bone cancer	0.000149	0.00116	CcSEcCtD
Etoricoxib—Flatulence—Doxorubicin—bone cancer	0.000148	0.00115	CcSEcCtD
Etoricoxib—PTGS2—C-MYB transcription factor network—KIT—bone cancer	0.000148	0.00143	CbGpPWpGaD
Etoricoxib—Chest pain—Methotrexate—bone cancer	0.000147	0.00115	CcSEcCtD
Etoricoxib—Arthralgia—Methotrexate—bone cancer	0.000147	0.00115	CcSEcCtD
Etoricoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—JUN—bone cancer	0.000147	0.00142	CbGpPWpGaD
Etoricoxib—Dysgeusia—Doxorubicin—bone cancer	0.000147	0.00115	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000146	0.00114	CcSEcCtD
Etoricoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—JUN—bone cancer	0.000145	0.0014	CbGpPWpGaD
Etoricoxib—Muscle spasms—Doxorubicin—bone cancer	0.000144	0.00112	CcSEcCtD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000144	0.00139	CbGpPWpGaD
Etoricoxib—Palpitations—Epirubicin—bone cancer	0.000143	0.00112	CcSEcCtD
Etoricoxib—Confusional state—Methotrexate—bone cancer	0.000143	0.00111	CcSEcCtD
Etoricoxib—Cough—Epirubicin—bone cancer	0.000141	0.0011	CcSEcCtD
Etoricoxib—Anaphylactic shock—Methotrexate—bone cancer	0.000141	0.0011	CcSEcCtD
Etoricoxib—Vision blurred—Doxorubicin—bone cancer	0.000141	0.0011	CcSEcCtD
Etoricoxib—MAPK14—B Cell Receptor Signaling Pathway—JUN—bone cancer	0.000141	0.00136	CbGpPWpGaD
Etoricoxib—Infection—Methotrexate—bone cancer	0.00014	0.0011	CcSEcCtD
Etoricoxib—Hypertension—Epirubicin—bone cancer	0.00014	0.00109	CcSEcCtD
Etoricoxib—MAPK14—MyD88-independent cascade—JUN—bone cancer	0.000139	0.00134	CbGpPWpGaD
Etoricoxib—Nervous system disorder—Methotrexate—bone cancer	0.000139	0.00108	CcSEcCtD
Etoricoxib—Anaemia—Doxorubicin—bone cancer	0.000139	0.00108	CcSEcCtD
Etoricoxib—MAPK14—p53 pathway—TP53—bone cancer	0.000138	0.00134	CbGpPWpGaD
Etoricoxib—Thrombocytopenia—Methotrexate—bone cancer	0.000138	0.00108	CcSEcCtD
Etoricoxib—Chest pain—Epirubicin—bone cancer	0.000138	0.00108	CcSEcCtD
Etoricoxib—Arthralgia—Epirubicin—bone cancer	0.000138	0.00108	CcSEcCtD
Etoricoxib—Agitation—Doxorubicin—bone cancer	0.000138	0.00108	CcSEcCtD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—MDM2—bone cancer	0.000138	0.00133	CbGpPWpGaD
Etoricoxib—Anxiety—Epirubicin—bone cancer	0.000138	0.00107	CcSEcCtD
Etoricoxib—Skin disorder—Methotrexate—bone cancer	0.000137	0.00107	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000137	0.00107	CcSEcCtD
Etoricoxib—MAPK14—Cellular responses to stress—GSTP1—bone cancer	0.000135	0.00131	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—JUN—bone cancer	0.000135	0.00131	CbGpPWpGaD
Etoricoxib—Dry mouth—Epirubicin—bone cancer	0.000135	0.00105	CcSEcCtD
Etoricoxib—Anorexia—Methotrexate—bone cancer	0.000135	0.00105	CcSEcCtD
Etoricoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	0.000134	0.0013	CbGpPWpGaD
Etoricoxib—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000134	0.0013	CbGpPWpGaD
Etoricoxib—Confusional state—Epirubicin—bone cancer	0.000133	0.00104	CcSEcCtD
Etoricoxib—Palpitations—Doxorubicin—bone cancer	0.000133	0.00103	CcSEcCtD
Etoricoxib—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000132	0.00128	CbGpPWpGaD
Etoricoxib—Anaphylactic shock—Epirubicin—bone cancer	0.000132	0.00103	CcSEcCtD
Etoricoxib—Oedema—Epirubicin—bone cancer	0.000132	0.00103	CcSEcCtD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—JUN—bone cancer	0.000132	0.00128	CbGpPWpGaD
Etoricoxib—Infection—Epirubicin—bone cancer	0.000131	0.00103	CcSEcCtD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000131	0.00127	CbGpPWpGaD
Etoricoxib—Cough—Doxorubicin—bone cancer	0.000131	0.00102	CcSEcCtD
Etoricoxib—Shock—Epirubicin—bone cancer	0.00013	0.00102	CcSEcCtD
Etoricoxib—MAPK14—Cellular Senescence—CDK4—bone cancer	0.00013	0.00126	CbGpPWpGaD
Etoricoxib—Nervous system disorder—Epirubicin—bone cancer	0.00013	0.00101	CcSEcCtD
Etoricoxib—Thrombocytopenia—Epirubicin—bone cancer	0.00013	0.00101	CcSEcCtD
Etoricoxib—Hypertension—Doxorubicin—bone cancer	0.00013	0.00101	CcSEcCtD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000129	0.00125	CbGpPWpGaD
Etoricoxib—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000129	0.001	CcSEcCtD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000129	0.00124	CbGpPWpGaD
Etoricoxib—Skin disorder—Epirubicin—bone cancer	0.000129	0.001	CcSEcCtD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—BRAF—bone cancer	0.000128	0.00124	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—TP53—bone cancer	0.000128	0.00124	CbGpPWpGaD
Etoricoxib—Insomnia—Methotrexate—bone cancer	0.000128	0.000997	CcSEcCtD
Etoricoxib—Chest pain—Doxorubicin—bone cancer	0.000128	0.000996	CcSEcCtD
Etoricoxib—Arthralgia—Doxorubicin—bone cancer	0.000128	0.000996	CcSEcCtD
Etoricoxib—Anxiety—Doxorubicin—bone cancer	0.000127	0.000993	CcSEcCtD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000127	0.00123	CbGpPWpGaD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000127	0.000989	CcSEcCtD
Etoricoxib—Anorexia—Epirubicin—bone cancer	0.000126	0.000984	CcSEcCtD
Etoricoxib—Dyspnoea—Methotrexate—bone cancer	0.000126	0.000983	CcSEcCtD
Etoricoxib—Somnolence—Methotrexate—bone cancer	0.000126	0.00098	CcSEcCtD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—TP53—bone cancer	0.000125	0.00121	CbGpPWpGaD
Etoricoxib—Dry mouth—Doxorubicin—bone cancer	0.000125	0.000974	CcSEcCtD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000125	0.00121	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—JUN—bone cancer	0.000125	0.00121	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—BRAF—bone cancer	0.000125	0.00121	CbGpPWpGaD
Etoricoxib—Dyspepsia—Methotrexate—bone cancer	0.000124	0.000971	CcSEcCtD
Etoricoxib—Confusional state—Doxorubicin—bone cancer	0.000123	0.000963	CcSEcCtD
Etoricoxib—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000123	0.00119	CbGpPWpGaD
Etoricoxib—Decreased appetite—Methotrexate—bone cancer	0.000123	0.000959	CcSEcCtD
Etoricoxib—Anaphylactic shock—Doxorubicin—bone cancer	0.000122	0.000955	CcSEcCtD
Etoricoxib—Oedema—Doxorubicin—bone cancer	0.000122	0.000955	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Methotrexate—bone cancer	0.000122	0.000952	CcSEcCtD
Etoricoxib—Fatigue—Methotrexate—bone cancer	0.000122	0.000951	CcSEcCtD
Etoricoxib—Infection—Doxorubicin—bone cancer	0.000122	0.000949	CcSEcCtD
Etoricoxib—MAPK14—Gene Expression—FUS—bone cancer	0.000121	0.00117	CbGpPWpGaD
Etoricoxib—Pain—Methotrexate—bone cancer	0.000121	0.000943	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000121	0.00094	CcSEcCtD
Etoricoxib—Shock—Doxorubicin—bone cancer	0.00012	0.000939	CcSEcCtD
Etoricoxib—Nervous system disorder—Doxorubicin—bone cancer	0.00012	0.000936	CcSEcCtD
Etoricoxib—Thrombocytopenia—Doxorubicin—bone cancer	0.00012	0.000935	CcSEcCtD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—JUN—bone cancer	0.00012	0.00116	CbGpPWpGaD
Etoricoxib—Insomnia—Epirubicin—bone cancer	0.00012	0.000933	CcSEcCtD
Etoricoxib—PTGS2—Spinal Cord Injury—CDK4—bone cancer	0.000119	0.00116	CbGpPWpGaD
Etoricoxib—Skin disorder—Doxorubicin—bone cancer	0.000119	0.000927	CcSEcCtD
Etoricoxib—Dyspnoea—Epirubicin—bone cancer	0.000118	0.00092	CcSEcCtD
Etoricoxib—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000118	0.00114	CbGpPWpGaD
Etoricoxib—Somnolence—Epirubicin—bone cancer	0.000118	0.000917	CcSEcCtD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—JUN—bone cancer	0.000117	0.00114	CbGpPWpGaD
Etoricoxib—Anorexia—Doxorubicin—bone cancer	0.000117	0.00091	CcSEcCtD
Etoricoxib—Feeling abnormal—Methotrexate—bone cancer	0.000117	0.000909	CcSEcCtD
Etoricoxib—Dyspepsia—Epirubicin—bone cancer	0.000116	0.000908	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Methotrexate—bone cancer	0.000116	0.000902	CcSEcCtD
Etoricoxib—Decreased appetite—Epirubicin—bone cancer	0.000115	0.000897	CcSEcCtD
Etoricoxib—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000115	0.00111	CbGpPWpGaD
Etoricoxib—Gastrointestinal disorder—Epirubicin—bone cancer	0.000114	0.000891	CcSEcCtD
Etoricoxib—Fatigue—Epirubicin—bone cancer	0.000114	0.00089	CcSEcCtD
Etoricoxib—MAPK14—Hemostasis—SPARC—bone cancer	0.000114	0.0011	CbGpPWpGaD
Etoricoxib—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000113	0.0011	CbGpPWpGaD
Etoricoxib—Constipation—Epirubicin—bone cancer	0.000113	0.000882	CcSEcCtD
Etoricoxib—Pain—Epirubicin—bone cancer	0.000113	0.000882	CcSEcCtD
Etoricoxib—MAPK14—Cellular Senescence—RB1—bone cancer	0.000113	0.00109	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	0.000113	0.00109	CbGpPWpGaD
Etoricoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000112	0.00109	CbGpPWpGaD
Etoricoxib—Urticaria—Methotrexate—bone cancer	0.000112	0.000876	CcSEcCtD
Etoricoxib—Abdominal pain—Methotrexate—bone cancer	0.000112	0.000872	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000112	0.00087	CcSEcCtD
Etoricoxib—Insomnia—Doxorubicin—bone cancer	0.000111	0.000864	CcSEcCtD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—JUN—bone cancer	0.00011	0.00107	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.00011	0.00106	CbGpPWpGaD
Etoricoxib—Dyspnoea—Doxorubicin—bone cancer	0.000109	0.000851	CcSEcCtD
Etoricoxib—Feeling abnormal—Epirubicin—bone cancer	0.000109	0.00085	CcSEcCtD
Etoricoxib—Somnolence—Doxorubicin—bone cancer	0.000109	0.000849	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Epirubicin—bone cancer	0.000108	0.000844	CcSEcCtD
Etoricoxib—Dyspepsia—Doxorubicin—bone cancer	0.000108	0.00084	CcSEcCtD
Etoricoxib—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000106	0.00103	CbGpPWpGaD
Etoricoxib—Decreased appetite—Doxorubicin—bone cancer	0.000106	0.00083	CcSEcCtD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—bone cancer	0.000106	0.00103	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	0.000106	0.00103	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—JUN—bone cancer	0.000106	0.00102	CbGpPWpGaD
Etoricoxib—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000106	0.000824	CcSEcCtD
Etoricoxib—Fatigue—Doxorubicin—bone cancer	0.000106	0.000823	CcSEcCtD
Etoricoxib—Urticaria—Epirubicin—bone cancer	0.000105	0.00082	CcSEcCtD
Etoricoxib—Pain—Doxorubicin—bone cancer	0.000105	0.000816	CcSEcCtD
Etoricoxib—Constipation—Doxorubicin—bone cancer	0.000105	0.000816	CcSEcCtD
Etoricoxib—Abdominal pain—Epirubicin—bone cancer	0.000105	0.000816	CcSEcCtD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—JUN—bone cancer	0.000105	0.00101	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Methotrexate—bone cancer	0.000104	0.000812	CcSEcCtD
Etoricoxib—PTGS2—Spinal Cord Injury—RB1—bone cancer	0.000104	0.00101	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—GNA11—bone cancer	0.000104	0.001	CbGpPWpGaD
Etoricoxib—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000104	0.001	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—JUN—bone cancer	0.000103	0.000995	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000103	0.000994	CbGpPWpGaD
Etoricoxib—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000102	0.000988	CbGpPWpGaD
Etoricoxib—Asthenia—Methotrexate—bone cancer	0.000101	0.000791	CcSEcCtD
Etoricoxib—Feeling abnormal—Doxorubicin—bone cancer	0.000101	0.000787	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Doxorubicin—bone cancer	0.0001	0.000781	CcSEcCtD
Etoricoxib—Pruritus—Methotrexate—bone cancer	0.0001	0.00078	CcSEcCtD
Etoricoxib—MAPK14—Cellular responses to stress—CDK4—bone cancer	9.82e-05	0.00095	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Epirubicin—bone cancer	9.75e-05	0.00076	CcSEcCtD
Etoricoxib—Urticaria—Doxorubicin—bone cancer	9.73e-05	0.000758	CcSEcCtD
Etoricoxib—Abdominal pain—Doxorubicin—bone cancer	9.68e-05	0.000755	CcSEcCtD
Etoricoxib—Diarrhoea—Methotrexate—bone cancer	9.67e-05	0.000754	CcSEcCtD
Etoricoxib—MAPK14—Cellular Senescence—MDM2—bone cancer	9.63e-05	0.000932	CbGpPWpGaD
Etoricoxib—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	9.6e-05	0.00093	CbGpPWpGaD
Etoricoxib—CYP2D6—Biological oxidations—CYP3A4—bone cancer	9.52e-05	0.000922	CbGpPWpGaD
Etoricoxib—Asthenia—Epirubicin—bone cancer	9.49e-05	0.00074	CcSEcCtD
Etoricoxib—MAPK14—Insulin Signaling—JUN—bone cancer	9.44e-05	0.000914	CbGpPWpGaD
Etoricoxib—CYP2C9—Biological oxidations—CYP3A4—bone cancer	9.44e-05	0.000914	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	9.43e-05	0.000913	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL3—bone cancer	9.41e-05	0.000911	CbGpPWpGaD
Etoricoxib—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	9.39e-05	0.000909	CbGpPWpGaD
Etoricoxib—Pruritus—Epirubicin—bone cancer	9.36e-05	0.00073	CcSEcCtD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—JUN—bone cancer	9.35e-05	0.000905	CbGpPWpGaD
Etoricoxib—Dizziness—Methotrexate—bone cancer	9.35e-05	0.000729	CcSEcCtD
Etoricoxib—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	9.31e-05	0.000901	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	9.26e-05	0.000896	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	9.09e-05	0.00088	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—JUN—bone cancer	9.08e-05	0.000879	CbGpPWpGaD
Etoricoxib—Diarrhoea—Epirubicin—bone cancer	9.05e-05	0.000706	CcSEcCtD
Etoricoxib—Hypersensitivity—Doxorubicin—bone cancer	9.02e-05	0.000703	CcSEcCtD
Etoricoxib—Vomiting—Methotrexate—bone cancer	8.99e-05	0.000701	CcSEcCtD
Etoricoxib—Rash—Methotrexate—bone cancer	8.92e-05	0.000695	CcSEcCtD
Etoricoxib—Dermatitis—Methotrexate—bone cancer	8.91e-05	0.000695	CcSEcCtD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	8.88e-05	0.000859	CbGpPWpGaD
Etoricoxib—Headache—Methotrexate—bone cancer	8.86e-05	0.000691	CcSEcCtD
Etoricoxib—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.85e-05	0.000857	CbGpPWpGaD
Etoricoxib—Asthenia—Doxorubicin—bone cancer	8.78e-05	0.000685	CcSEcCtD
Etoricoxib—Dizziness—Epirubicin—bone cancer	8.75e-05	0.000682	CcSEcCtD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—bone cancer	8.73e-05	0.000845	CbGpPWpGaD
Etoricoxib—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	8.73e-05	0.000845	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—ATF1—bone cancer	8.69e-05	0.000841	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—KIT—bone cancer	8.67e-05	0.000839	CbGpPWpGaD
Etoricoxib—Pruritus—Doxorubicin—bone cancer	8.66e-05	0.000675	CcSEcCtD
Etoricoxib—PTGS2—Metabolism—NDUFA12—bone cancer	8.54e-05	0.000827	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—RB1—bone cancer	8.54e-05	0.000826	CbGpPWpGaD
Etoricoxib—Vomiting—Epirubicin—bone cancer	8.41e-05	0.000656	CcSEcCtD
Etoricoxib—MAPK14—Gene Expression—NR1I2—bone cancer	8.4e-05	0.000813	CbGpPWpGaD
Etoricoxib—Nausea—Methotrexate—bone cancer	8.4e-05	0.000655	CcSEcCtD
Etoricoxib—Diarrhoea—Doxorubicin—bone cancer	8.38e-05	0.000653	CcSEcCtD
Etoricoxib—MAPK14—Cellular Senescence—JUN—bone cancer	8.37e-05	0.00081	CbGpPWpGaD
Etoricoxib—Rash—Epirubicin—bone cancer	8.34e-05	0.000651	CcSEcCtD
Etoricoxib—Dermatitis—Epirubicin—bone cancer	8.34e-05	0.00065	CcSEcCtD
Etoricoxib—Headache—Epirubicin—bone cancer	8.29e-05	0.000646	CcSEcCtD
Etoricoxib—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.22e-05	0.000796	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	8.2e-05	0.000793	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—BRAF—bone cancer	8.15e-05	0.000789	CbGpPWpGaD
Etoricoxib—CYP2D6—Biological oxidations—GSTP1—bone cancer	8.14e-05	0.000788	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	8.13e-05	0.000787	CbGpPWpGaD
Etoricoxib—Dizziness—Doxorubicin—bone cancer	8.1e-05	0.000631	CcSEcCtD
Etoricoxib—CYP2C9—Biological oxidations—GSTP1—bone cancer	8.07e-05	0.000781	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—CYP3A4—bone cancer	8.07e-05	0.000781	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NDUFA12—bone cancer	8.04e-05	0.000779	CbGpPWpGaD
Etoricoxib—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	8.03e-05	0.000777	CbGpPWpGaD
Etoricoxib—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	7.96e-05	0.000771	CbGpPWpGaD
Etoricoxib—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	7.96e-05	0.00077	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—bone cancer	7.9e-05	0.000765	CbGpPWpGaD
Etoricoxib—Nausea—Epirubicin—bone cancer	7.86e-05	0.000613	CcSEcCtD
Etoricoxib—Vomiting—Doxorubicin—bone cancer	7.78e-05	0.000607	CcSEcCtD
Etoricoxib—Rash—Doxorubicin—bone cancer	7.72e-05	0.000602	CcSEcCtD
Etoricoxib—Dermatitis—Doxorubicin—bone cancer	7.71e-05	0.000601	CcSEcCtD
Etoricoxib—Headache—Doxorubicin—bone cancer	7.67e-05	0.000598	CcSEcCtD
Etoricoxib—PTGS2—Spinal Cord Injury—MMP9—bone cancer	7.49e-05	0.000725	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—EGFR—bone cancer	7.35e-05	0.000712	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—MDM2—bone cancer	7.28e-05	0.000705	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	7.28e-05	0.000704	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	7.28e-05	0.000704	CbGpPWpGaD
Etoricoxib—Nausea—Doxorubicin—bone cancer	7.27e-05	0.000567	CcSEcCtD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TP53—bone cancer	7.27e-05	0.000704	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—EGFR—bone cancer	7.14e-05	0.000691	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NT5C3A—bone cancer	7.08e-05	0.000685	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—GSTP1—bone cancer	6.9e-05	0.000668	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—MDM2—bone cancer	6.83e-05	0.000661	CbGpPWpGaD
Etoricoxib—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	6.8e-05	0.000659	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NT5C3A—bone cancer	6.66e-05	0.000645	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	6.44e-05	0.000624	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—JUN—bone cancer	6.33e-05	0.000612	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GRM4—bone cancer	6.3e-05	0.00061	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RGS1—bone cancer	6.3e-05	0.00061	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NDUFA12—bone cancer	6.21e-05	0.000601	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—EIF2S1—bone cancer	6.2e-05	0.0006	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—PLAU—bone cancer	6.17e-05	0.000598	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	6.07e-05	0.000587	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—EGFR—bone cancer	6.05e-05	0.000586	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	6.02e-05	0.000583	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TP53—bone cancer	6e-05	0.00058	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—CDK4—bone cancer	5.95e-05	0.000576	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MET—bone cancer	5.95e-05	0.000576	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NDUFA12—bone cancer	5.71e-05	0.000552	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NDUFA12—bone cancer	5.66e-05	0.000548	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—TP53—bone cancer	5.53e-05	0.000535	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GRM1—bone cancer	5.46e-05	0.000529	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	5.41e-05	0.000524	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—EZH2—bone cancer	5.39e-05	0.000522	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.32e-05	0.000515	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.25e-05	0.000508	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	5.24e-05	0.000507	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NT5C3A—bone cancer	5.14e-05	0.000498	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TP53—bone cancer	5.08e-05	0.000492	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ATF1—bone cancer	5.06e-05	0.00049	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MMP2—bone cancer	4.96e-05	0.00048	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—KIT—bone cancer	4.94e-05	0.000479	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL3—bone cancer	4.93e-05	0.000478	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NDUFA12—bone cancer	4.84e-05	0.000468	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NT5C3A—bone cancer	4.73e-05	0.000458	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NT5C3A—bone cancer	4.69e-05	0.000454	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—EGFR—bone cancer	4.67e-05	0.000452	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—TP53—bone cancer	4.18e-05	0.000404	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.12e-05	0.000399	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NT5C3A—bone cancer	4.01e-05	0.000388	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—MDM2—bone cancer	3.89e-05	0.000377	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SMO—bone cancer	3.85e-05	0.000372	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NDUFA12—bone cancer	3.73e-05	0.000361	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MMP9—bone cancer	3.73e-05	0.000361	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ENO2—bone cancer	3.7e-05	0.000358	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GNA11—bone cancer	3.52e-05	0.000341	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.46e-05	0.000335	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—DHFR—bone cancer	3.44e-05	0.000333	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—JUN—bone cancer	3.38e-05	0.000328	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ATF1—bone cancer	3.27e-05	0.000317	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL3—bone cancer	3.19e-05	0.000309	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ENO2—bone cancer	3.1e-05	0.0003	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NT5C3A—bone cancer	3.09e-05	0.000299	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—EGFR—bone cancer	3.01e-05	0.000292	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ENO2—bone cancer	2.92e-05	0.000283	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—KIT—bone cancer	2.88e-05	0.000279	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—DHFR—bone cancer	2.88e-05	0.000278	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFBR2—bone cancer	2.73e-05	0.000264	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—DHFR—bone cancer	2.71e-05	0.000262	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GNA11—bone cancer	2.69e-05	0.00026	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—EGFR—bone cancer	2.66e-05	0.000258	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF1R—bone cancer	2.57e-05	0.000249	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GNA11—bone cancer	2.53e-05	0.000245	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFBR2—bone cancer	2.49e-05	0.000241	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—bone cancer	2.48e-05	0.00024	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP3A4—bone cancer	2.44e-05	0.000236	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP3A4—bone cancer	2.29e-05	0.000222	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MDM2—bone cancer	2.27e-05	0.00022	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ENO2—bone cancer	2.25e-05	0.000218	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—DHFR—bone cancer	2.09e-05	0.000202	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTP1—bone cancer	2.08e-05	0.000202	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ENO2—bone cancer	2.07e-05	0.000201	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ENO2—bone cancer	2.05e-05	0.000199	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—JUN—bone cancer	1.97e-05	0.000191	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTP1—bone cancer	1.96e-05	0.00019	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GNA11—bone cancer	1.95e-05	0.000189	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—DHFR—bone cancer	1.92e-05	0.000186	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—DHFR—bone cancer	1.91e-05	0.000184	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KIT—bone cancer	1.86e-05	0.00018	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GNA11—bone cancer	1.8e-05	0.000174	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GNA11—bone cancer	1.78e-05	0.000172	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP3A4—bone cancer	1.77e-05	0.000171	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.76e-05	0.000171	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ENO2—bone cancer	1.75e-05	0.00017	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—BRAF—bone cancer	1.75e-05	0.000169	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—KIT—bone cancer	1.7e-05	0.000164	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP3A4—bone cancer	1.63e-05	0.000158	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—DHFR—bone cancer	1.63e-05	0.000158	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP3A4—bone cancer	1.61e-05	0.000156	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.61e-05	0.000155	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—BRAF—bone cancer	1.6e-05	0.000155	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EGFR—bone cancer	1.55e-05	0.00015	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GNA11—bone cancer	1.52e-05	0.000147	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTP1—bone cancer	1.51e-05	0.000147	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MDM2—bone cancer	1.47e-05	0.000142	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTP1—bone cancer	1.39e-05	0.000135	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTP1—bone cancer	1.38e-05	0.000134	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP3A4—bone cancer	1.38e-05	0.000134	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.37e-05	0.000133	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ENO2—bone cancer	1.35e-05	0.000131	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MDM2—bone cancer	1.34e-05	0.000129	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—JUN—bone cancer	1.27e-05	0.000123	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—DHFR—bone cancer	1.26e-05	0.000122	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP9—bone cancer	1.24e-05	0.00012	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTP1—bone cancer	1.18e-05	0.000114	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GNA11—bone cancer	1.17e-05	0.000114	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—bone cancer	1.02e-05	9.84e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EGFR—bone cancer	1e-05	9.7e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EGFR—bone cancer	9.14e-06	8.85e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTP1—bone cancer	9.11e-06	8.81e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—bone cancer	8.41e-06	8.14e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—bone cancer	7.84e-06	7.59e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—bone cancer	7.22e-06	6.98e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—bone cancer	7.15e-06	6.92e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—bone cancer	6.11e-06	5.92e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—bone cancer	4.72e-06	4.57e-05	CbGpPWpGaD
